Does
IMPORTANT SAFETY INFORMATION
INDICATIONS FOR USE The RECELL® Autologous Cell Harvesting Device is indicated for the treatment of acute thermal burn wounds in patients 18 years of age and older. The RECELL® device is used by an appropriately-licensedhealthcare professional at the patient’s point of care to prepare autologous Regenerative Epidermal Suspension (RES™for direct application to acute partial-thickness thermal burn wounds or application in combination with meshed autografting for acute full-thickness thermal burn wounds.
CONTRAINDICATIONS RECELL® is contraindicated for: the treatment of wounds clinically diagnosed as infected or with necrotic tissue…
cover half of everyone else's screen????
other AVH website, page-2
-
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$3.06 |
Change
-0.160(4.97%) |
Mkt cap ! $215.7M | |||
| Open | High | Low | Value | Volume |
| $3.17 | $3.17 | $3.05 | $559.2K | 180.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 10230 | $3.06 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $3.07 | 1000 | 1 |
View Market Depth
| Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
| AVH (ASX) Chart |